j2hbio

GondolaBio

This biopharmaceutical company develops clinical-stage and preclinical medicinal therapeutics for patients living with rare genetic diseases.

Actio Biosciences

This biotechnology company develops small molecule medicines to treat rare genetic diseases and common conditions for patients with high unmet medical needs.

Biopharmaceutical company

This firm develops small molecule drugs targeting protein regulatory sites to treat patients with cancer and autoimmune diseases.

1200 Pharma

This biotechnology firm develops small molecule therapies and drug intellectual property for the treatment of cancer patients.

Hawkhill Therapeutics

This company develops oral small molecule therapies for obesity and metabolic health to preserve muscle mass for the biotechnology and pharmaceutical sectors.

Bridge BIO

This biopharmaceutical company develops and provides medicines for patients with genetic diseases and cancers with clear genetic drivers.

Redx Pharma

This clinical-stage biotechnology company develops small molecule medicines for fibrotic diseases and oncology for pharmaceutical partners and patients with unmet medical needs.

J-Pharma

This company develops small molecule drugs targeting SLC transporters for patients with biliary tract cancer and multiple sclerosis.